Related Experiment Video
Updated: Sep 24, 2025
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.2K
Raf kinase inhibitory protein reduces bradykinin receptor desensitization.
Samuel B Chivers1, Allison Doyle Brackley2, Nathaniel A Jeske1,2,3
1Departments of Oral & Maxillofacial Surgery, University of Texas Health San Antonio, San Antonio, Texas, USA.
Journal of Neurochemistry
|May 8, 2022
Summary
Raf Kinase Anchoring Protein (RKIP) prevents bradykinin receptor desensitization in neurons. This protein scaffolding inhibits inflammatory hyperalgesia by maintaining receptor activation, offering new therapeutic targets.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Inflammatory hyperalgesia can persist due to protein modifications.
- Intracellular signaling's role in persistent inflammatory phenotypes is not fully understood.
Purpose of the Study:
- To investigate the role of Raf Kinase Anchoring Protein (RKIP) in bradykinin (BK) receptor desensitization.
- To elucidate how RKIP integrates intracellular signaling to regulate inflammatory pain pathways.
Main Methods:
- Biochemical analyses of primary neuronal cultures.
- Studying bradykinin-stimulated phosphorylation of RKIP by PKC.
- Assessing GRK2 binding to RKIP upon BK exposure.
- Real-time imaging to observe BK receptor desensitization with RKIP down-regulation.
Main Results:
- Bradykinin stimulates PKC phosphorylation of RKIP at Ser153.
- BK exposure increases GRK2 binding to RKIP, inhibiting BK receptor desensitization.
- RKIP down-regulation enhances BK receptor desensitization in primary afferent neurons.
Conclusions:
- RKIP acts as a scaffolding protein that inhibits BK receptor desensitization.
- RKIP interrupts a key pathway for canonical desensitization, maintaining BK receptor activation.
- RKIP is a crucial pathway integrator controlling multiple GRK2-sensitive G-protein coupled receptors.
Related Concept Videos
01:12GPCR Desensitization
6.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.6K
01:20The JAK-STAT Signaling Pathway
9.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.4K
01:26Receptor Tyrosine Kinases
14.6K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.6K
01:22Amplifying Signals via Enzymatic Cascade
10.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
10.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
533
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
533
01:20Desensitization and Tachyphylaxis
2.3K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.3K